Geneva-based ORamaVR raises USD 4.5 million to scale medical XR training solutions
30 January 2026
The team at ORamaVR develops AI-powered extended reality solutions designed to improve medical training, planning and navigation through immersive simulation. | © ORamaVR
ORamaVR has raised USD 4.5 million in late-seed funding to accelerate the commercial rollout of its AI-powered medical extended reality platform for surgical training and device simulation.
Medtech start-up ORamaVR has secured USD 4.5 million in late-seed financing to support the expansion of its Computational Medical Extended Reality (CMXR) platform. The funding round was led by Big Pi Ventures and Evercurious VC, with participation from existing and new strategic investors.
The financing combines equity investments and convertible loans and brings together healthcare-focused investors, deep-tech venture capital firms and individual technology entrepreneurs. Existing shareholders, including FORTH-ICS and Starttech Ventures, joined the round, alongside new investors such as Sofmedica Ventures and Lars Rasmussen, co-founder of Google Maps.
ORamaVR develops immersive software solutions that integrate artificial intelligence, medical knowledge and extended reality to support training, planning, navigation and rehabilitation in clinical settings. The company’s primary commercial focus is on XR-based training for medical devices and surgical robotics, allowing healthcare professionals to train in high-fidelity simulated environments comparable to flight simulators used in aviation.
Scaling commercial deployment in medical training
The new funding will be used to expand product development and sales activities, particularly in collaboration with medical device manufacturers and surgical robot providers. ORamaVR also announced the appointment of Jan Grund Pedersen as Chief Business Officer, strengthening its commercial leadership as the company scales internationally.
Previously validated in clinical studies, ORamaVR’s platform has demonstrated measurable improvements in surgical performance and error reduction. With this latest funding, the company aims to accelerate adoption of medical XR technologies and position itself as a leading provider of advanced digital training tools for healthcare systems worldwide.